Clinical Development
Achieve your regulatory milestone faster with better decision-making and less re-work
The stakes are never higher than in the clinical phase of your drug development program – nearly 60% of drugs entering Phase III failing to achieve regulatory approval. By providing a longitudinal evaluation of disease-specific metabolic signatures during a trial, our Targeted Metabolomics Solution enhances monitoring of individual patient response to drug metabolism and toxicity, as well as provides improved post-approval drug monitoring.
Our Process: Working with Metabolon
Related Resources
Enlighten your research,
accelerate your discovery.
Contact Us
Talk with an expert
Request a quote for our services or more information on sample types and handling procedures, need a letter of support, or simply have questions about how metabolomics can advance your research.
617 Davis Drive, Suite 100
Morrisville, NC 27560
Mailing Address:
P.O. Box 110407
Research Triangle Park, NC 27709
Metabolon GmbH
Zeppelinstraße 3
85399 Hallbergmoos
Germany